ID
32451
Beskrivning
Study ID: 102248 Clinical Study ID: 102248 Study Title: Multi-Center Study to Assess the Efficacy, Safety and Immunogenicity of 2 or 3 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine Given Concomitantly With Routine EPI Vaccinations in Healthy Infants Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00241644 Study Link: https://clinicaltrials.gov/ct2/show/NCT00241644 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Rotavirus Vaccine Trade Name: Rotarix Study Indication: Infections, Rotavirus The visits are defined as follows: Visit 1: (Study/Participation) Day 0, Age: 5-10 weeks, Dose 1 Visit 2: (Study/Participation) Month 1, 30-48 days after Visit 1, Dose 2 Visit 3: (Study/Participation) Month 2, 30-48 days after Visit 2, Dose 3 Visit 4: (Study/Participation) Month 3, 30-48 days after Visit 3, Visit 5: (Study/Participation) 1 year of age, 343-391 days of age For amendment 5: Visit 5: (Study/Participation) 21-48 days after Visit 4 Visit 6: (Study/Participation) 1 year of age, 343-391 days of age This form defines when a subject should be excluded from the study or when a vaccination should be postponed. The form should be checked at each visit subsequent to the first visit.
Länk
https://clinicaltrials.gov/ct2/show/NCT00241644
Nyckelord
Versioner (1)
- 2018-11-01 2018-11-01 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
1 november 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Efficacy, Safety and Immunogenicity of Oral HRV Vaccine NCT00241644
Elimination Criteria
- StudyEvent: ODM
Beskrivning
Elimination Criteria During the Study
Alias
- UMLS CUI-1
- C0680251
Beskrivning
Use of investigational or non-registered product other than study vaccine
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0013230
- UMLS CUI [2,1]
- C0332300
- UMLS CUI [2,2]
- C1521826
- UMLS CUI [2,3]
- C0042210
Beskrivning
Chronic administration of immunosuppressants except topic
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0021081
- UMLS CUI [1,2]
- C0205191
- UMLS CUI [2,1]
- C0332300
- UMLS CUI [2,2]
- C1522168
- UMLS CUI [2,3]
- C0038317
Beskrivning
Administration of other vaccine
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C2368628
- UMLS CUI [1,2]
- C0205394
Beskrivning
Administration of immunoglobulins or blood products
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0021027
- UMLS CUI [2]
- C0371802
Beskrivning
Contraindication to Subsequent Vaccination
Alias
- UMLS CUI-1
- C1301624
- UMLS CUI-2
- C0042196
Beskrivning
Hypersensitivity to vaccine
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C1521826
- UMLS CUI [1,3]
- C0042210
Beskrivning
Intussusception
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0021933
Beskrivning
The following AEs constitute contraindications to administration of HRV vaccine or placebo at that point in time; if any one of these AEs occurs at the time scheduled for vaccination, the subject may be vaccinated at a later date, within the time window specified in the protocol, or withdrawn at the discretion of the investigator. The subject must be followed until resolution of the event, as with any AE
Datatyp
float
Måttenheter
- °C
Alias
- UMLS CUI [1]
- C0489749
- UMLS CUI [2]
- C1531924
Beskrivning
The following AEs constitute contraindications to administration of HRV vaccine or placebo at that point in time; if any one of these AEs occurs at the time scheduled for vaccination, the subject may be vaccinated at a later date, within the time window specified in the protocol, or withdrawn at the discretion of the investigator. The subject must be followed until resolution of the event, as with any AE
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0017160
Similar models
Elimination Criteria
- StudyEvent: ODM
C0332300 (UMLS CUI [2,1])
C1521826 (UMLS CUI [2,2])
C0042210 (UMLS CUI [2,3])
C0205191 (UMLS CUI [1,2])
C0332300 (UMLS CUI [2,1])
C1522168 (UMLS CUI [2,2])
C0038317 (UMLS CUI [2,3])
C0205394 (UMLS CUI [1,2])
C0371802 (UMLS CUI [2])
C0042196 (UMLS CUI-2)
C1521826 (UMLS CUI [1,2])
C0042210 (UMLS CUI [1,3])
C1531924 (UMLS CUI [2])